Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Case Rep ; 17(1): 227, 2023 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-37254193

RESUMO

BACKGROUND: Opportunistic infections associated with immunosuppressive treatments for inflammatory bowel disease pose an important safety concern. Here we report the case of a patient with active ulcerative colitis and cryptococcal pneumonia who was treated with vedolizumab combined with fluconazole. CASE PRESENTATION: A 56-year-old Japanese man with ulcerative colitis and a history of Sweet's syndrome who was taking prednisolone and azathioprine presented with a moderate exacerbation of ulcerative colitis, abdominal pain, diarrhea, and bloody stools along with cytomegalovirus infection. Increasing the prednisolone dose without using antiviral drugs improved cytomegalovirus infection; however, ulcerative colitis did not improve, and cryptococcal pneumonia occurred. Thus, treatment with fluconazole followed by vedolizumab was initiated for ulcerative colitis. The patient gradually recovered and achieved clinical remission without the exacerbation of pneumonia. CONCLUSIONS: We reported the first case of a patient with ulcerative colitis who was treated with vedolizumab and concomitant fluconazole for active cryptococcal pneumonia. Vedolizumab constitutes a high-potential treatment regimen owing to its safety in inflammatory bowel disease associated with opportunistic infections.


Assuntos
Colite Ulcerativa , Infecções por Citomegalovirus , Doenças Inflamatórias Intestinais , Infecções Oportunistas , Masculino , Humanos , Pessoa de Meia-Idade , Colite Ulcerativa/complicações , Colite Ulcerativa/tratamento farmacológico , Fluconazol/uso terapêutico , Doenças Inflamatórias Intestinais/complicações , Prednisolona/uso terapêutico , Infecções por Citomegalovirus/complicações , Infecções por Citomegalovirus/tratamento farmacológico
2.
Chemistry ; 26(23): 5162-5167, 2020 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-31951065

RESUMO

Fluorescence-phosphorescence dual-emissive compounds are valuable tools for ratiometric luminescence sensing. Herein, it is reported that 2,5-bis(phenylsulfonyl)- and 2,5-bis[bis(4-methoxyphenyl)phosphinyl]-1,4-disiloxybenzenes exhibit dual emission with emission peaks that were easily identified without performing time-gated measurement. The disiloxybenzenes in powder simultaneously fluoresced and phosphoresced at 358-374 and 457-470 nm, respectively, under vacuum. The intensity ratios of the phosphorescence/fluorescence maxima of the disiloxybenzenes in powder and in a thin film of poly(methyl methacrylate) were sensitive to temperature and molecular oxygen, respectively. The plots of the relative intensity versus temperature or partial pressure of molecular oxygen were well fitted with calibration curves defined by an exponential approximation with excellent correlation coefficients R2 (0.9708-0.9921), demonstrating the high potential of the disiloxybenzenes as precious metal-free probes applicable to ratiometric luminescence sensing.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...